HOME › DRUGS › SUTIMLIMAB-JOME
ACTIVE SUBSTANCE / INN

SUTIMLIMAB-JOME

Brand name(s): ENJAYMO
FDA LISTED
PRESCRIPTION
BLA761164
ACTIVE SUBSTANCE
Sutimlimab-Jome
REGULATORS
FDA
SPONSORS / MAH
RECORDATI RARE DISEASES, INC.
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ENJAYMOBLA761164RECORDATI RARE DISEASES, INC.Prescription

FULL INTELLIGENCE ON SUTIMLIMAB-JOME

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →